Literature DB >> 1952929

The release of heparinase from the periplasmic space of Flavobacterium heparinum by three-step osmotic shock.

J J Zimmermann1, K Oddie, R Langer, C L Cooney.   

Abstract

Heparinase was released from the periplasmic space of Flavobacterium heparinum by three-step osmotic shock procedure. The procedure involves resuspending exponentially growing cells consecutively into (1) 40% sucrose, (2) 10 mM sodium phosphate, 2 mM magnesium chloride, pH 7, and (3) 10 mM sodium phosphate, 300 mM sodium chloride, 2 mM magnesium chloride, pH 7. Typically, 50-75% of the total heparinase activity is recovered by this procedure with an observed 7-15-fold increase in purity. The majority of heparinase activity is released in the final step of the procedure allowing for resolution from cytoplasmic and nonspecific periplasmic material. F. heparinum cells can be stored in 40% sucrose at 4 degrees C for up to one week without significant losses in recovery yields.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1952929     DOI: 10.1007/bf02921681

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  15 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  The enzymatic degradation of heparin and heparitin sulfate. I. The fractionation of a crude heparinase from flavobacteria.

Authors:  A Linker; P Hovingh
Journal:  J Biol Chem       Date:  1965-10       Impact factor: 5.157

3.  The release of enzymes by osmotic shock from Escherichia coli in exponential phase.

Authors:  N G Nossal; L A Heppel
Journal:  J Biol Chem       Date:  1966-07-10       Impact factor: 5.157

4.  The release of enzymes from Escherichia coli by osmotic shock and during the formation of spheroplasts.

Authors:  H C Neu; L A Heppel
Journal:  J Biol Chem       Date:  1965-09       Impact factor: 5.157

5.  Areas of adhesion between wall and membrane of Escherichia coli.

Authors:  M E Bayer
Journal:  J Gen Microbiol       Date:  1968-10

6.  Differential anticoagulant activity of heparin fragments prepared using microbial heparinase.

Authors:  R J Linhardt; A Grant; C L Cooney; R Langer
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

7.  Production and ultrastructure of lysozyme and ethylenediaminetetraacetate-lysozyme spheroplasts of Escherichia coli.

Authors:  D C Birdsell; E H Cota-Robles
Journal:  J Bacteriol       Date:  1967-01       Impact factor: 3.490

8.  Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone.

Authors:  J Folkman; R Langer; R J Linhardt; C Haudenschild; S Taylor
Journal:  Science       Date:  1983-08-19       Impact factor: 47.728

9.  Heparinase production by Flavobacterium heparinum.

Authors:  P M Galliher; C L Cooney; R Langer; R J Linhardt
Journal:  Appl Environ Microbiol       Date:  1981-02       Impact factor: 4.792

10.  Purification and characterization of heparinase from Flavobacterium heparinum.

Authors:  V C Yang; R J Linhardt; H Bernstein; C L Cooney; R Langer
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

View more
  2 in total

1.  Isolation and expression in Escherichia coli of hepB and hepC, genes coding for the glycosaminoglycan-degrading enzymes heparinase II and heparinase III, respectively, from Flavobacterium heparinum.

Authors:  H Su; F Blain; R A Musil; J J Zimmermann; K Gu; D C Bennett
Journal:  Appl Environ Microbiol       Date:  1996-08       Impact factor: 4.792

2.  Isolation and expression in Escherichia coli of cslA and cslB, genes coding for the chondroitin sulfate-degrading enzymes chondroitinase AC and chondroitinase B, respectively, from Flavobacterium heparinum.

Authors:  A L Tkalec; D Fink; F Blain; G Zhang-Sun; M Laliberte; D C Bennett; K Gu; J J Zimmermann; H Su
Journal:  Appl Environ Microbiol       Date:  2000-01       Impact factor: 4.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.